The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma

European Journal of Gynaecological Oncology

Volumn 20, Issue 4, 1999, Pages 315-317

  Cherchi, Pier Luigi ^a   Dessole, S ^b   Ruiu, G A ^b   Ambrosini, G ^b   Farina, M ^b   Capobianco, G ^b   Ambrosini, A ^b  

^a Ist di Ginecologia ed Ostetricia   (Italy)

^b NONE

Author keywords

CA 125; CA 19 9; Endometrial carcinoma; Tumor markers

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; RELAPSE;

ADENOCARCINOMA; ADULT; AGED; CA-125 ANTIGEN; CA-19-9 ANTIGEN; ENDOMETRIAL NEOPLASMS; EVALUATION STUDIES; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033491277     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ambrosini A., Cherchi P. L.: "Follow-up of gynaecological malignancies with monoclonal antibodies". In: "Research reports on Gynaecology and Obstetrics". Parthenon Publishing Group Ed., Carnforth, 1989, 435.
2. Benedetti Panici P. L., Scambia G., Baiocchi G., Perrone L., Greggi S., Mancuso S.: "Multiple serum markers in patients with endometrial cancer". Gynecol. Obstet. Invest., 1989, 27, 208.
3. Fukazawa I., Inaba N., Ota Y., Sato N., Shirotake S., Iwasawa H. et al.: "Serum levels of six tumor markers in patients with benign and malignant gynecological disease". Arch. Gynecol. Obstet., 1988, 243, 61.
4. Cherchi P. L., Esposito F., Vargiu N., Ambrosini A.: "Tumor markers in endometrial cancer". In: "Current investigations in Gynecology and Obstetrics". Parthenon Publishing Group Ed., Carnforth, 1993, 405.
5. Hustin J.: "Immunohistochemical demonstration of several tumor markers in neoplastic and preneoplastic states of uterine mucosa". Gynecol. Obstet. Invest., 1978, 9, 3.
6. Neunteufel W., Bieglmayer C., Breitenecker G.: "CA 19-9. CA 125 and CEA in endometrial carcinoma tissue and its relation to hormone receptor content and histological grading". Arch. Gynecol. Obstet., 1988, 244, 47.
7. Matorras R., Rodriguez-Escudero F. J., Diez J., Genolla J., Fombellida J. C., Ruibal A.: "Monitoring endometrial adenocarcinoma with a four tumor marker combination". Acta Obst. Gyn. Scand., 1992, 71, 458.
8. Soper J. T., Berchuck A., Olt G. J., Soisson A. P., Clarke-Pearson D. L., Bast R. C.: "Preoperative evaluation of serum CA 125, TAG 72 and CA 15-3 in patients with endometrial carcinoma". Am. J. Obstet. Gynecol., 1990, 163, 1204.
9. Gocze P. M., Szabo D. G., Than G. N., Csaba I. F., Krommer K. F.: "Occurrence of CA 125 and CA 19-9 tumor-associated antigens in sera of patients with gynecologic, trophoblastic, and colon-rectal tumors". Gynecol. Obstet. Invest., 1988, 25, 268.
10. Podczaski E., Kaminski P., Hackett T. E., Olt G., Zaino R.: "Tissue CA 125 and CA 19-9 in malignant, mixed mesodermal tumors of the uterus". Gynecol. Oncol., 1993, 49, 56.
11. Scharl A., Crombach G., Vierbuchen M., Gohring U. J., Gottert T., Holt J.: "Antigen CA 19-9 presence in mucosa of non diseased mullerian duct derivates and marker for differentiation in their carcinomas". Obst. Gyn., 1991, 77, 580.
12. Lundqvist E. A., Nordstrom L., Sjovall K., Eneroth P.: "Evaluation of seven different tumor markers for the establishment of tumor marker panels in gynecologic malignancies". Eur. J. Gynecol. Oncol., 1989, X (6), 395.
13. Patsner B., Tenhoppen D. J., Mann W. J.: "Use of serum CA 125 levels to monitor therapy of patients with advanced or recurrent endometrial carcinoma". Eur. J. Gynecol. Oncol., 1989, X, (5), 322.
14. De Bruijn H. W. A., Ten Hoor K. A., Duk M. J., Krans M., Aalders J. G.: "Endometrial cancer and the biology of tumor markers". In: "Current Investigations in Gynecology and Obstetrics". Parthenon Publishing Group Ed., Carnforth, 1993, 219.
15. Duk J. M., Aalders J. G., Fleuren G. J., Bruijn H. W. A.: "CA 125, a useful marker in endometrial carcinoma". Am. J. Obstet. Gynecol., 1986, 155, 1097.
16. Fanning J., Piver S.: "Serial CA 125 levels during chemotherapy for metastatic or recurrent endometrial cancer". Obst. Gyn., 1991, 77, 278.
17. Patsner B., Orr J. W., Mann W. J.: "Use of serum CA 125 measurement in post-treatment surveillance of early-stage endometrial carcinoma". Am. J. Obst. Gyn., 1990, 162, 421.
18. Patsner B., Mann W. J., Cohen H., Loesch M.: "Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma". Am. J. Obstet. Gynecol., 1988, 158, 399.
19. Niloff J. M., Klug T., Schaetzl E., Zurawski R., Knapp R. C., Bast R. C.: "Elevation of serum CA 125 in carcinomas of fallopian tube, endometrium and endocervix". Am. J. Obstet. Gynecol., 1984, 48, 1057.